Home › Burkitt Lymphoma › Texas

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Texas

23 pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Research Site, Houston

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07109219

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Methodist Children's Hospital, San Antonio

Nagre-recruitPhase 1

Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06173518

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
at 10 pa

Nagre-recruitPhase 2

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04546399

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Texas Children's Hospital, Houston

Nagre-recruitPhase 3

Edad 1 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07223021

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Houston Methodist Hospital, Houston

Nagre-recruitPhase 3

Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

University of Texas MD Anderson Cancer Center ( Site 1007), Houston

Nagre-recruitPhase 1/2

6 Months – 25 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06395103

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Texas Children's Hospital, Houston

Nagre-recruitObservasyonal na pag-aaral

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
at 7 pa

Nagre-recruitPhase 2

365 Days · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
at 10 pa

Nagre-recruitPhase 2

366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06124157

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

University of Texas MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1/2

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06533579

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

The University of Texas MD Anderson Cancer Center, Houston

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07648264

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Houston

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT06137118

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Baylor University Medical Center, Dallas

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03666000

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
at 12 pa

Nagre-recruitPhase 3

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

University of Texas, Southwestern, Dallas
Baylor Texas Children's Hospital, Houston

Nagre-recruitPhase 2

Edad 7 hanggang 25 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05082519

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06287229

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

M D Anderson Cancer Center, Houston

Nagre-recruitPhase 2

Edad 15 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT03136146

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

M D Anderson Cancer Center, Houston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT01371630

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

M D Anderson Cancer Center, Houston

Nagre-recruitPhase 2

Edad 14 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT02877303

Study of SGR-1505 in Mature B-Cell Neoplasms

University of Texas Southwestern, Dallas

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

University of Texas MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

The University of Texas M. D. Anderson Cancer Center, Houston
Methodist Healthcare System, San Antonio

Nagre-recruitPhase 2

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update May 4, 2025 · NCT03509961

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.